Ticaros
Seongdong
About Ticaros
Ticaros is a biotech company that develops immune anti-cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Mar 2026)
- Website: ticaros.comkr
- Phone: +82 02 745 6655
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/ticaros-83253 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.